The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
- On April 4, 2020, the FDA issued guidance on clinical electronic thermometers that immediately went into effect. Fever is a common symptom of COVID-19 and clinical electronic thermometers are an important screening and diagnostic tool to assist in the identification of those individuals who may be infected with COVID-19. The policy set forth in the guidance may help expand the availability of ...
No comments:
Post a Comment